没食子酸增强造血干细胞移植后T细胞的移植物抗白血病效应而不加重移植物抗宿主病
该研究在体外和白血病小鼠模型中证实,天然膳食化合物没食子酸(GA)可增强T细胞介导的移植物抗白血病(GVL)效应,表现为T细胞活化和细胞毒性细胞因子分泌增加、AML细胞凋亡、白血病小鼠生存延长和白血病细胞浸润减少;GA通过激活MAPK和NF-κB通路发挥作用,且不加速移植物抗宿主病(GVHD)进展。
要点
- 没食子酸(GA)在体外增强T细胞活化及细胞毒性细胞因子分泌,促进AML细胞凋亡。
- 在非照射白血病小鼠模型中,GA延长白血病小鼠生存并减少白血病细胞浸润。
- GA通过激活MAPK和NF-κB通路增强GVL效应,且不加速GVHD进展。
核心结论
- 没食子酸(GA)可增强T细胞的移植物抗白血病(GVL)效应而不加重移植物抗宿主病(GVHD),为改善造血干细胞移植后患者结局提供思路。
研究设计与样本
- 研究采用体外共培养系统和non-irradiated白血病小鼠模型,评估没食子酸(GA)对T细胞介导的GVL效应及GVHD的影响。
主要发现
- GA处理的T细胞在体外共培养系统中活化和细胞毒性细胞因子分泌增加,导致AML细胞凋亡。
- 在非照射白血病小鼠模型中,GA治疗延长白血病小鼠生存并减少白血病细胞浸润。
- GA治疗增加T细胞活化和肿瘤坏死因子-α分泌。
- 整合转录组和蛋白质组分析表明,GA通过激活MAPK和NF-κB通路增强T细胞介导的GVL效应;单独阻断这些通路削弱GA在AML模型小鼠中的保护作用。
- GA给药在小鼠模型中未加速移植物抗宿主病(GVHD)进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is an effective therapy for acute myeloid leukaemia (AML), predominantly due to its potent graft-versus-leukaemia (GVL) effect. However, leukaemia relapse remains a major obstacle to the success of allo-HSCT. In this study, we demonstrated that gallic acid (GA), a natural dietary compound, can enhance T-cell-mediated GVL effects both in vitro and in vivo. GA-treated T cells exhibited increased activation and elevated secretion of cytotoxic cytokines, leading to the apoptosis of AML cells in co-culture systems in vitro. In a non-irradiated leukaemia mouse model, we showed that GA treatment prolonged the survival of leukaemic mice and reduced leukaemia cell infiltration. Further analysis revealed that GA treatment increased T-cell activation and tumour necrosis factor-α secretion. Moreover, integrated transcriptomic and proteomic analyses indicated that GA augments T-cell-mediated GVL effects through the activation of the MAPK and NF-κB pathways. Blocking these pathways individually diminished the protective effect of GA in AML model mice. Importantly, GA administration did not accelerate graft-versus-host disease (GVHD) progression in a mouse model. In conclusion, our study revealed that GA can enhance the GVL effects of T cells without exacerbating GVHD, offering insights into its potential to improve outcomes for patients after HSCT.
引用
- Huang Q, Jiang X, Wang B, et al. Gallic acid enhances GVL effects of T cells without exacerbating GVHD after haematopoietic stem cell transplantation. Br J Haematol. 2024. PMID: 39472128. doi:10.1111/bjh.19863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。